| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jan 25 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | No | 12.18 | 8,966 | 109.21 k | 77,388 |
| 1 Jan 25 | NTLA Intellia Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,500 | 0.00 | 86,354 |
| 1 Jan 25 | NTLA Intellia Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,500 | 0.00 | 0 |
| 29 May 24 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 49,220 | 0.00 | 49,220 |
| 29 May 24 | TSHA Taysha Gene Therapies | Stock Option Common Stock | Grant | Acquire A | No | No | 3.17 | 98,440 | 312.05 k | 98,440 |
| 1 Mar 24 | NTLA Intellia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 37,966 | 0.00 | 81,893 |
| 1 Mar 24 | NTLA Intellia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 32.66 | 54,794 | 1.79 mm | 54,794 |
| 8 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 29.38 | 667 | 19.60 k | 43,927 |
| 8 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 28.66 | 1,608 | 46.09 k | 44,594 |
